Evidence map›Paper›PMID 37752740›Full record

ArticleESC heart failure2023

Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10 years survival.

Vilas Wagh, Filomain Nguemo, Zlata Kiseleva, Robert M Mader, Juergen Hescheler, Werner Mohl

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. The Phoenix Heart-PICSO and the Rebirth of Embryonic Life in the Ischemic Myocardium.Journal of cardiovascular development and disease · 2026
    Review
  2. RNA Therapeutics in Heart Failure.Journal of cardiovascular translational research · 2025
    Review
  3. Article
  4. Review
  5. 2024 update in heart failure.ESC heart failure · 2025
    Review
  6. Observational
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Vilas WaghMerck Research Labs, Boston, MA, USA.
Filomain NguemoCenter of Physiology and Pathophysiology, Institute of Neurophysiology, University of Cologne, Cologne, Germany.
Zlata KiselevaDepartment of Cardiac Surgery emeritus, Medical University Vienna, Vienna, Austria.
Robert M MaderDepartment of Medicine I, Medical University Vienna, Vienna, Austria.
Juergen HeschelerCenter of Physiology and Pathophysiology, Institute of Neurophysiology, University of Cologne, Cologne, Germany.
Werner MohlDepartment of Cardiac Surgery emeritus, Medical University Vienna, Vienna, Austria.
Medical University of Vienna · ATUniversity of Cologne · DE

Funding

Austrian Science Fund P13274-MedFederal Ministry of Traffic, Innovation, and Technology BMVIT GZ609.637/000-III/12/2004Society of Coronary Sinus Interventions 001/2017
6 · The paper itself

Abstract

aimsMechanochemical signalling drives organogenesis and is highly conserved in mammal evolution. Regaining recovery in myocardial jeopardy by inducing principles linking cardiovascular therapy and clinical outcome has been the dream of scientists for decades. Concepts involving embryonic pathways to regenerate adult failing hearts became popular in the early millennium. Since then, abundant data on stem cell research have been published, never reaching widespread application in heart failure therapy. Another conceptual access, using mechanotransduction in cardiac veins to limit myocardial decay, is pressure-controlled intermittent coronary sinus occlusion (PICSO). Recently, we reported acute molecular signs and signals of PICSO activating regulatory miRNA and inducing cell proliferation mimicking cardiac development in adult failing hearts. According to a previously formulated hypothesis, 'embryonic recall', this study aimed to define molecular signals involved in endogenous heart repair during PICSO and study their relation to patient survival. METHODS AND

resultsWe previously reported a study on the acute molecular effects of PICSO in an observational non-randomized study. Eight out of the thirty-two patients with advanced heart failure undergoing cardiac resynchronization therapy (CRT) were treated with PICSO. Survival was monitored over 10 years, and coronary sinus blood samples were collected during intervention before and after 20 min and tested for miRNA signalling and proliferation when co-cultured with cardiomyocytes. A numerically lower death rate post-CRT and PICSO as compared with control CRT only, and a non-significant reduction in all-cause mortality risk of 42% was observed (37.5% vs. 54.0%, relative risk = 0.58, 95% confidence interval: 0.17-2.05; P = 0.402). Four miRNAs involved in cell cycle, proliferation, morphogenesis, embryonic development, and apoptosis significantly increased concomitantly in survivors and PICSO compared with a decrease in non-survivors (hsa-miR Let7b, P < 0.01; hsa-miR- 421, P < 0.006; hsa-miR 363-3p, P < 0.03 and hsa-miR 19b-3p P < 0.01). In contrast, three miRNAs involved in proliferation and survival, determining cell fate, and recycling endosomes decreased in survivors and PICSO (hsa miR 101-3p, P < 0.03; hsa-miR 25-3p, P < 002; hsa-miR 30d-5p P < 0.04). In vitro cellular proliferation increased in survivors and lowered in non-survivors showing a pattern distinction, discriminating longevity according to up to 10-year survival in heart failure patients.

conclusionsThis study proposes that generating regenerative signals observed during PICSO intervention relate to patient outcomes. Morphogenetic pathways induced by periods of flow reversal in cardiac veins in a domino-like pattern transform embryonic into regenerative signals. Studies supporting the conversion of mechanochemical signals into regenerative molecules during PICSO are warranted to substantiate predictive power on patient longevity, opening new therapeutic avenues in otherwise untreatable heart failure.

Indexed as

Circulating MicroRNAHeart FailureMicroRNAsAdultAnimalsCell ProliferationHumansMammalsMechanotransduction, CellularMyocytes, CardiacCirculating MicroRNAMicroRNAsMIRN363 microRNA, humanCardiac regenerationCirculating miRNAsEmbryonic recallHeart failurePICSO

Identifiers

PMID37752740
PMCPMC10682869
OpenAlexW4387077197

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.